Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · IEX Real-Time Price · USD
2.59
+0.12 (4.86%)
At close:
May 26, 2023, 4:00 PM
2.60
+0.01 (0.39%)
Pre-market:
May 30, 2023, 5:41 AM EDT
Eyenovia Market Cap
Eyenovia has a market cap or net worth of $98.43 million as of May 30, 2023. Its market cap has increased by 45.17% in one year.
Market Cap
98.43M
Enterprise Value
90.96M
1-Year Change
45.17%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since January 25, 2018, Eyenovia's market cap has decreased from $98.60M to $98.43M, a decrease of -0.17%. That is a compound annual growth rate of -0.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 26, 2023 | 98.40M | 4.79% |
May 25, 2023 | 93.90M | -13.62% |
May 24, 2023 | 108.70M | -6.86% |
May 23, 2023 | 116.70M | -3.71% |
May 22, 2023 | 121.20M | -0.33% |
May 19, 2023 | 121.60M | -4.48% |
May 18, 2023 | 127.30M | -6.19% |
May 17, 2023 | 135.70M | 5.36% |
May 16, 2023 | 128.80M | 2.88% |
May 15, 2023 | 125.20M | -4.79% |
May 12, 2023 | 131.50M | -15.16% |
May 11, 2023 | 155.00M | -5.78% |
May 10, 2023 | 164.50M | 1.86% |
May 9, 2023 | 161.50M | -3.81% |
May 8, 2023 | 167.90M | -3.95% |
May 5, 2023 | 174.80M | -8.15% |
May 4, 2023 | 190.30M | -12.91% |
May 3, 2023 | 218.50M | 2.53% |
May 2, 2023 | 213.10M | 6.02% |
May 1, 2023 | 201.00M | -0.54% |
Apr 28, 2023 | 202.10M | 6.37% |
Apr 27, 2023 | 190.00M | 8.26% |
Apr 26, 2023 | 175.50M | 2.45% |
Apr 25, 2023 | 171.30M | -7.05% |
Apr 24, 2023 | 184.30M | -1.02% |
View and export this data all the way back to 2018.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Augmedix, Inc. | 149.28M |
Opiant Pharmaceuticals, Inc. | 108.80M |
Galectin Therapeutics Inc. | 95.33M |
BriaCell Therapeutics Corp. | 93.81M |
HCW Biologics Inc. | 59.22M |
Viracta Therapeutics, Inc. | 56.08M |
Minerva Surgical, Inc. | 40.67M |
Centogene N.V. | 22.21M |
Journey Medical Corporation | 19.21M |